EUROIMMUN Medizinische Labordiagnostika AG
Corporate brand
UnclaimedGerman medical laboratory diagnostics manufacturer based in Lübeck, founded in 1987 and part of Revvity, Inc.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Euroimmun is a manufacturer of medical laboratory diagnostics. According to its company profile, more than 3500 employees in 17 countries develop, produce and sell test systems to support the diagnosis of diseases, as well as software and automation solutions for the performance and evaluation of these tests. Laboratories in over 150 countries use Euroimmun products for the diagnosis of autoimmune and infectious diseases as well as allergies, and to perform genetic analyses. The company was founded in 1987 from the University of Lübeck (Germany). In 2018 the US American company PerkinElmer, Inc. became the sole shareholder of Euroimmun; in 2023 the PerkinElmer business divisions "Life Sciences" and "Diagnostics" were converted into the new company Revvity, Inc., which also includes Euroimmun. Euroimmun's product portfolio spans autoimmunity, infectious diseases, allergy, endocrinology, bone metabolism, neurodegeneration, therapeutic drug monitoring, research parameters and automation.
History
Euroimmun was founded in 1987 from the University of Lübeck (Germany). Among its initial pioneering achievements was the development of BIOCHIPs in 1983. In 2018, the US American company PerkinElmer, Inc. became the sole shareholder of Euroimmun. In 2023, the two PerkinElmer business divisions "Life Sciences" and "Diagnostics" were converted into the new company Revvity, Inc., which also includes Euroimmun.
Products and positioning
One of the leading manufacturers of medical laboratory diagnostics worldwide, standing for innovation.
Anti-Oropouche virus ELISAs
Supporting the diagnosis of Oropouche fever, now also available in the European market
Anti-nephrin autoantibodies test
A promising biomarker in nephrology
Singleplex assays (ChLIAs)
Test systems for in vitro determination of specific IgE antibodies
Multiplex assays (EUROLINE)
Test systems for in vitro determination of specific IgE antibodies
EUROBlotOne
A compact tabletop device for complete processing of immunoblots
EUROBlotMaster
Compact tabletop devices for processing Euroimmun blot strips (EUROLINE, EUROLINE-WB, Westernblot)
Recent events
EUROIMMUN launches quantitative SARS-CoV-2 antibody test[6]
EUROIMMUN launched the Anti-SARS-CoV-2 QuantiVac ELISA (IgG), a quantitative test to measure IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is available in countries accepting the CE mark; the company planned to seek U.S. FDA Emergency Use Authorization.
Sources6 sources
Cite this profile: Cite the canonical profile. /brand-wiki/euroimmun-medizinische-labordiagnostika-ag-germany · Editorial policy · How profiles are compiled